SUPN Supernus Pharmaceuticals
- 34.700
- +0.730+2.15%
- 37.000
- +2.300+6.63%
Supernus Pharmaceuticals News
Supernus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Macquarie Group Limited(4.78%),Macquarie Management Holdings Inc(4.78%), etc.
Supernus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Dimensional Fund Advisors LP(5.2%)
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottola Frank
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SIEBERT JOHN M
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hudson Frederick M.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Barlow Carrolee
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director NEWHALL CHARLES W III
Analysis
Price Target
No Data
No Data